The dynamic change of lymphocyte immune function before and after CIK therapy

Two weeks after the immunotherapy with cytokine-induced killer cells (CIK), the comparison value of CD3+, CD4+T cells, NK (Natural Killer) cells and CD4+/CD8+ significantly increased compare with the pre-treatment status, and the value continues to increase with the time being, 2 – 4 weeks after the cancer immunotherapy, this value reached its peak point, after this point, the level of the patient’s immune response declines. 8 weeks after the CIK immunotherapy, the value of CD3+, CD4+T cells, NK cells and CD4+/CD8+ in the peripheral blood declined to a lower level, but the value maintains higher than the control group.

Kidney Cancer
Share this article

Effective and affordable immunotherapy and CAR T-cell Therapy?

Contact us and get detailed information about getting advanced immunotherapy and CAR T-cell therapy for the treatment of solid tumors, blood cancers and HPV infection.